Understanding the Power of Magnetic Resonance Therapy -- MRT(sm) -- from the Parent’s Perspective.
Dr. Bradstreet will introduce the science of MRT(sm) and the ongoing research into brain physics and then introduce a panel of parents to further describe a balanced view of what may be expected from this unique form of intervention. In MRT treatment, BTC has augmented the well-established and safe technique of transcranial magnetic stimulation (TMS) through a proprietary algorithm to deliver a patient-specific treatment based on the results of a quantitative electroencephalogram (EEG) and electrocardiography (ECG).
James Jeffrey Bradstreet, MD
Dr. Bradstreet received undergrad and medical degrees from University of South Florida. His residency training was at Wilford Hall USAF Medical Center, with training at Brooks School of Aerospace Medicine and Randolph AFB. He is an adjunct professor and faculty for Autism Collaboration & Education at Western U in CA and a visiting professor at Southwest College of Naturopathic Medicine. He is extensively published on biomedical issues of autism and was PI of two landmark studies: 1) involving a new methodology to view the brain with ultrasound, and 2) a double-blind study of the use of transcranial magnetic stimulation using a method known as MRT, for the treatment of autism -- both registered with clinicaltrials.gov. Phase one of the ultrasound study was recently published in Frontiers in Human Neuroscience, and the MRT study completed in June of 2014. He is director of the Brain Treatment Center of Atlanta and is licensed in Georgia, Florida, California and Arizona.
Kevin Murphy, MD
Dr. Murphy received his MS in neurophysiology from Purdue University and his MD from the University of Chicago’s Pritzker School of Medicine. Dr. Murphy completed his Radiation Oncology Residency in the Department of Radiation and Cellular Oncology at the University of Chicago. In May 2005, he was recruited to the Department of Radiation Oncology at the University of California, San Diego (UCSD). Dr. Murphy's clinical and research interests focus on the application of a number of novel technologies in the treatment of brain tumors in both adults and children. Dr. Murphy serves as the Chief of the UCSD Pediatric Radiation Oncology Service and is an active member of the Children’s Oncology Group (COG). Dr. Murphy is a regional resource and primary radiation oncologist for Rady Children’s Hospital and Health Center, San Diego. He is on the advisory board of the Brain Treatment Center in Newport Beach, CA.
Keynote - The Autism Nexus: New Discoveries of Links Among the Gut Microbiome, the Immune System, and Brain Dysfunction and What YOU Can Do!
Premier researchers Dr. James Jeffrey Bradstreet,. Prof. Dr. Marco Ruggiero of Italy, and Dr. Yi Jin of the Newport Brain Research Center will present cutting-edge innovations in autism therapies. Their research can explain the relationship of the immune system to brain function. Topics include vitamin D deficiency, vitamin D binding protein (GcMAF), magnetic resonant therapy (MRT), a unique application of transcranial magnetic brain stimulation, transcranial ultrasound (TUS), and the body’s endocannabinoid system.
Yi Jin, MD
Dr. Yi Jin is a psychiatrist with 30 years of neuroscience research experiences. He is a faculty members at both UCSD and USC. He has co-founded two biomed companies, Neosync, Inc. and Newport Brain Research Laboratory (NBRL), and currently holds positions of COB and CMO in NBRL.
Marco Ruggiero, PhD, MD
Earned a PhD in molecular biology and is a doctor specializing in clinical radiology. He worked at Burroughs Wellcome, publishing a seminal paper with Nobel Laureate Sir John Vane, and subsequently at the National Cancer Institute of the NIH. He has published more than 150 peer-reviewed scientific papers. For 20 years he has worked on the vitamin D axis, a metabolic pathway that includes GcMAF. In the past 3 years he has published studies on the immunotherapeutic effects of GcMAF in a variety of conditions.
James Jeffrey Bradstreet, MD, MD(H) FAAFP, FMAPS
Dr. Bradstreet is extensively published and involved in ongoing research into the immune system and brain physics (TMS/MRT) of autism. He is on faculty at Western University of Health Sciences Faculty for Autism Collaboration and Education (FACE) and is working with the faculty to develop innovative biomedical techniques to restore functionality to individuals with autism spectrum disorders. He recent publications cover topics in immunology, brain imaging and stem cell interventions.
Keynote - The Autism Nexus: New ...
By Mike Healy, 9 years 47 weeks agoPremier researchers Dr. James Jeffrey Bradstreet,. Prof. Dr. Marco Ruggiero of Italy, and Dr.
How Close Are We To An Autism Cure? Part 1
Dr. Bradstreet has been involved in autism related treatment and clinical research for nearly 2 decades. During that time, the theory of a genetic cause of autism has continued to decline, while the emergence of the “environment-gene” interaction theory of autism has gained in favor among scientists and parents. Clearly, autism is one of the most complex of all human disorders and challenges our understanding of the gut ecosystem, the immune pathways in the gut and the brain, and, ultimately, the regulation of brain physics.
James Jeffrey Bradstreet, MD
Dr. Bradstreet received undergrad and medical degrees from University of South Florida. His residency training was at Wilford Hall USAF Medical Center, with training at Brooks School of Aerospace Medicine and Randolph AFB. He is an adjunct professor and faculty for Autism Collaboration & Education at Western U in CA and a visiting professor at Southwest College of Naturopathic Medicine. He is extensively published on biomedical issues of autism and was PI of two landmark studies: 1) involving a new methodology to view the brain with ultrasound, and 2) a double-blind study of the use of transcranial magnetic stimulation using a method known as MRT, for the treatment of autism -- both registered with clinicaltrials.gov. Phase one of the ultrasound study was recently published in Frontiers in Human Neuroscience, and the MRT study completed in June of 2014. He is director of the Brain Treatment Center of Atlanta and is licensed in Georgia, Florida, California and Arizona.
How Close Are We To An Autism Cure? Part 2
Although toxins from industry, agriculture, and more shape the environment for children with autism, the largest and most impacted environmental factor for autism remains the internal ecosystem living in the intestines. That environment is shaped by complex communities of microbes interacting with the diet and the immune defenses of the child. The combined effect of environmental poisons and microbial chemistry directly influence the immune system in critical ways, while also affecting gene expression.
James Jeffrey Bradstreet, MD
Dr. Bradstreet received undergrad and medical degrees from University of South Florida. His residency training was at Wilford Hall USAF Medical Center, with training at Brooks School of Aerospace Medicine and Randolph AFB. He is an adjunct professor and faculty for Autism Collaboration & Education at Western U in CA and a visiting professor at Southwest College of Naturopathic Medicine. He is extensively published on biomedical issues of autism and was PI of two landmark studies: 1) involving a new methodology to view the brain with ultrasound, and 2) a double-blind study of the use of transcranial magnetic stimulation using a method known as MRT, for the treatment of autism -- both registered with clinicaltrials.gov. Phase one of the ultrasound study was recently published in Frontiers in Human Neuroscience, and the MRT study completed in June of 2014. He is director of the Brain Treatment Center of Atlanta and is licensed in Georgia, Florida, California and Arizona.
Advances in Understanding the Gut-Immune-Brain Link in Autism -- CME program for medical professionals
This course will explore the latest research on the microbiota regulation of the endocannabinoid and immune systems. The attendee will become familiar with the components of the endocannabinoid system (ECS) and understand what fatty acids act as natural ligands for the various receptors. They will understand the difference between type 1 and 2 receptors as well as the transient receptor potential vanilloid type 1 ion channel and the unique G-couple receptors and their function.
James Jeffrey Bradstreet, MD
Dr. Bradstreet received undergrad and medical degrees from University of South Florida. His residency training was at Wilford Hall USAF Medical Center, with training at Brooks School of Aerospace Medicine and Randolph AFB. He is an adjunct professor and faculty for Autism Collaboration & Education at Western U in CA and a visiting professor at Southwest College of Naturopathic Medicine. He is extensively published on biomedical issues of autism and was PI of two landmark studies: 1) involving a new methodology to view the brain with ultrasound, and 2) a double-blind study of the use of transcranial magnetic stimulation using a method known as MRT, for the treatment of autism -- both registered with clinicaltrials.gov. Phase one of the ultrasound study was recently published in Frontiers in Human Neuroscience, and the MRT study completed in June of 2014. He is director of the Brain Treatment Center of Atlanta and is licensed in Georgia, Florida, California and Arizona.
Effective Therapies for Autism: Ranging from Brain Physics to Immunological Interventions for the Gut and the Brain
Over the past 17 years I have attempted to explore and document what forms of therapy work for individuals with autism related issues. The key is the individual rather than the statistics of group responses. One child may need intensive metal detoxification, while another needs advanced immunological treatments. One child may respond vigorously the hyperbaric oxygen while another begins speaking in sentences after transcranial magnetic therapy.
James Jeffrey Bradstreet , MD, MD(H) FAAFP, FMAPS
Dr. Bradstreet is extensively published and involved in ongoing research into the immune system and brain physics (TMS/MRT) of autism. He is on faculty at Western University of Health Sciences Faculty for Autism Collaboration and Education (FACE) and is working with the faculty to develop innovative biomedical techniques to restore functionality to individuals with autism spectrum disorders. He recent publications cover topics in immunology, brain imaging and stem cell interventions.
.
.
Rapid Clearing of Autism Symptoms with NeuroModulation Technique - A New Healing Modality
